General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
Treatment Advocacy Center
NEWS
FOR
IMMEDIATE RELEASE December 16, 1998 |
CONTACT: |
703 294 6008 or [email protected] |
Testifying before the City agencies that will make recommendations to the State Legislature about the future of outpatient civil commitment in New York, Jaffe, who also serves as coordinator for the NY Treatment Advocacy Coalition, said, "Outpatient commitment helps control the symptoms that cause people with these illnesses to become homeless, suicidal, incarcerated and violent. It would help the Larry Hoags and Keven Cerbellises of the world, while simultaneously keeping communities safer. Outpatient commitment is humane, cost-effective and practical."
A study released last week of the Bellevue outpatient commitment program, prepared for DMHMRAS by Policy Research Associates, revealed that individuals who received court ordered treatment in addition to enhanced community services spent 57 percent less time in psychiatric hospitals than individuals who received only enhanced services. Individuals who had both court ordered treatment and enhanced services spent only six weeks in the hospital, compared to 14 weeks for those who did not receive court orders.
"New York is one of the last states to implement outpatient commitment even though it repeatedly has been shown to be effective in other states," said Mary Zdanowicz, Executive Director of the Treatment Advocacy Center. In Washington, D.C., for example, admissions decreased from 1.81 per year to 0.95 per year before and after outpatient commitment; in Ohio the decrease was from 1.5 to 0.4; and in Iowa from 1.3 to 0.3. In North Carolina, admissions for patients on outpatient commitment decreased from 3.7 to 0.7 per 1,000 days. Another study in North Carolina demonstrated fewer psychiatric admissions and shorter lengths of stay for patients who received case management services enhanced by a court order (admissions - 0.34 per patient and length of stay 6.9 days) than for individuals who received case management without a court order (admissions 1.23 per patient and length of stay 20.1 days). "We believe the overall success of the Bellevue program in reducing the rates of rehospitalization and length of hospital stays warrants expanding outpatient commitment throughout New York," said Zdanowicz.
"We prevent people suffering from Alzheimers disease from living on the streets because we understand they have a brain disorder that prevents them from sufficiently caring for themselves," concluded Jaffe. "We mandate assisted treatment for individuals with tuberculosis who refuse to take medication because we understand they are potentially dangerous to other people. People suffering from the debilitating effects of neurobiological brain disorders deserve no less. Its time for New York to join 76 percent of the nation, and implement outpatient commitment programs that will enable thousands of New Yorkers once held hostage by their disease to escape their symptoms and enjoy real recovery."
###
The Treatment Advocacy Center (www.treatmentadvocacycenter.org) is a national nonprofit organization dedicated to eliminating barriers to the timely and effective treatment of severe mental illnesses. TAC promotes laws, policies, and practices for the delivery of psychiatric care and supports the development of innovative treatments for and research into the causes of severe and persistent psychiatric illnesses, such as schizophrenia and bipolar disorder.
ADDITIONAL INFORMATION
New York
activities | Kendra's
Law | press room
general
resources | legal resources | medical
resources | briefing papers | state activity
hospital closures | preventable
tragedies | press room | search
| home
The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products. Treatment Advocacy Center (TAC), 200 N. Glebe Road, Suite 730, Arlington, VA 22203 703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website) [email protected] (general email) | [email protected] (press contact) [email protected] (webmaster) |